Skip to main content

Cocaine Use clinical trials at UC Health
1 research study open to eligible people

  • Treatment With Lorcaserin for Cocaine Use: The TLC Study

    open to eligible males ages 18-65

    This project is a placebo-controlled, double-blind randomized trial evaluating the feasibility, tolerability, acceptability and adherence for lorcaserin among actively using, men who have sex with men (MSM) with cocaine use disorders.The study will enroll 45 individuals who will randomly be assigned to either the treatment (lorcaserin) arm or the placebo arm, to be taken twice a day for 12 weeks.

    at UCSF